BioMérieux Moves Forward With HPV, Sepsis Diagnostic Agreements
This article was originally published in The Gray Sheet
Executive Summary
BioMérieux announced two deals last week as part of its five-year strategic plan focusing on infectious diseases and personalized diagnostics